363 related articles for article (PubMed ID: 25172988)
21. Quantitative assessment of brain stem and cerebellar atrophy in spinocerebellar ataxia types 3 and 6: impact on clinical status.
Eichler L; Bellenberg B; Hahn HK; Köster O; Schöls L; Lukas C
AJNR Am J Neuroradiol; 2011 May; 32(5):890-7. PubMed ID: 21372168
[TBL] [Abstract][Full Text] [Related]
22. Brain single-photon emission computed tomography and magnetic resonance imaging in Machado-Joseph disease.
Etchebehere EC; Cendes F; Lopes-Cendes I; Pereira JA; Lima MC; Sansana CR; Silva CA; Camargo MF; Santos AO; Ramos CD; Camargo EE
Arch Neurol; 2001 Aug; 58(8):1257-63. PubMed ID: 11493166
[TBL] [Abstract][Full Text] [Related]
23. Dominantly inherited ataxias: lessons learned from Machado-Joseph disease/spinocerebellar ataxia type 3.
Paulson HL
Semin Neurol; 2007 Apr; 27(2):133-42. PubMed ID: 17390258
[TBL] [Abstract][Full Text] [Related]
24. Glucocerebrosidase gene variants in parkinsonian patients with Machado Joseph/spinocerebellar ataxia 3.
Siebert M; Donis KC; Socal M; Rieder CR; Emmel VE; Vairo F; Michelin-Tirelli K; França M; D'Abreu AC; Bettencourt C; Lima M; Lopes Cendes I; Saraiva-Pereira ML; Jardim LB
Parkinsonism Relat Disord; 2012 Feb; 18(2):185-90. PubMed ID: 22001711
[TBL] [Abstract][Full Text] [Related]
25. The blood-brain barrier is disrupted in Machado-Joseph disease/spinocerebellar ataxia type 3: evidence from transgenic mice and human post-mortem samples.
Duarte Lobo D; Nobre RJ; Oliveira Miranda C; Pereira D; Castelhano J; Sereno J; Koeppen A; Castelo-Branco M; Pereira de Almeida L
Acta Neuropathol Commun; 2020 Aug; 8(1):152. PubMed ID: 32867861
[TBL] [Abstract][Full Text] [Related]
26. Machado Joseph-Disease Is Rare in the Peruvian Population.
Cornejo-Olivas M; Solis-Ponce L; Araujo-Aliaga I; Milla-Neyra K; Ortega O; Illanes-Manrique M; Mazzetti P; Manrique-Enciso C; Cubas-Montecino D; Saraiva-Pereira ML; Jardim LB; Sarapura-Castro E
Cerebellum; 2023 Dec; 22(6):1192-1199. PubMed ID: 36323979
[TBL] [Abstract][Full Text] [Related]
27. Brain stem and cerebellum volumetric analysis of Machado Joseph disease patients.
Camargos ST; Marques W; Santos AC
Arq Neuropsiquiatr; 2011; 69(2B):292-6. PubMed ID: 21625753
[TBL] [Abstract][Full Text] [Related]
28. Spinocerebellar ataxia, type 3 (SCA3) is genetically identical to Machado-Joseph disease (MJD).
Haberhausen G; Damian MS; Leweke F; Müller U
J Neurol Sci; 1995 Sep; 132(1):71-5. PubMed ID: 8523034
[TBL] [Abstract][Full Text] [Related]
29. Profiling of mitochondrial genomes in SCA3/MJD patients from mainland China.
Yuan H; Yang H; Peng L; Peng Y; Chen Z; Wan L; Wang C; Shi Y; Zhang VW; Tang B; Qiu R; Jiang H
Gene; 2020 May; 738():144487. PubMed ID: 32087274
[TBL] [Abstract][Full Text] [Related]
30. Neuromelanin imaging analyses of the substantia nigra in patients with Machado-Joseph disease.
Nakata Y; Sakamoto A; Kawata A
Neuroradiology; 2020 Nov; 62(11):1433-1439. PubMed ID: 32556403
[TBL] [Abstract][Full Text] [Related]
31. Ophthalmological Features of Machado-Joseph Disease.
Rana AQ; Qureshi DT; Morshed M; Kachhvi ZM; Rana MA; Qureshi ARM
J Coll Physicians Surg Pak; 2016 Nov; 26(11):137-139. PubMed ID: 28666509
[TBL] [Abstract][Full Text] [Related]
32. Body mass index is inversely correlated with the expanded CAG repeat length in SCA3/MJD patients.
Saute JA; Silva AC; Souza GN; Russo AD; Donis KC; Vedolin L; Saraiva-Pereira ML; Portela LV; Jardim LB
Cerebellum; 2012 Sep; 11(3):771-4. PubMed ID: 22090366
[TBL] [Abstract][Full Text] [Related]
33. Structural alterations of spinocerebellar ataxias type 3: from pre-symptomatic to symptomatic stage.
Qiu H; Wu C; Liang J; Hu M; Chen Y; Huang Z; Yang Z; Zhao J; Chu J
Eur Radiol; 2023 Apr; 33(4):2881-2894. PubMed ID: 36370172
[TBL] [Abstract][Full Text] [Related]
34. MR Imaging of SCA3/MJD.
Wan N; Chen Z; Wan L; Tang B; Jiang H
Front Neurosci; 2020; 14():749. PubMed ID: 32848545
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA profiling in the serums of SCA3/MJD patients.
Shi Y; Huang F; Tang B; Li J; Wang J; Shen L; Xia K; Jiang H
Int J Neurosci; 2014 Feb; 124(2):97-101. PubMed ID: 23879331
[TBL] [Abstract][Full Text] [Related]
36. Sleep symptoms and their clinical correlates in Machado-Joseph disease.
D'Abreu A; França M; Conz L; Friedman JH; Nucci AM; Cendes F; Lopes-Cendes I
Acta Neurol Scand; 2009 Apr; 119(4):277-80. PubMed ID: 18771522
[TBL] [Abstract][Full Text] [Related]
37. [Clinical types of spinocerebellar degeneration and evaluation with MR imaging].
Kojima S
Rinsho Shinkeigaku; 1993 Dec; 33(12):1294-6. PubMed ID: 8174328
[TBL] [Abstract][Full Text] [Related]
38. Cerebellar morphometric and spectroscopic biomarkers for Machado-Joseph Disease.
Miranda CO; Nobre RJ; Paiva VH; Duarte JV; Castelhano J; Petrella LI; Sereno J; Santana M; Afonso S; Januário C; Castelo-Branco M; de Almeida LP
Acta Neuropathol Commun; 2022 Mar; 10(1):37. PubMed ID: 35305685
[TBL] [Abstract][Full Text] [Related]
39. No parkinsonism in SCA2 and SCA3 despite severe neurodegeneration of the dopaminergic substantia nigra.
Schöls L; Reimold M; Seidel K; Globas C; Brockmann K; Hauser TK; Auburger G; Bürk K; den Dunnen W; Reischl G; Korf HW; Brunt ER; Rüb U
Brain; 2015 Nov; 138(Pt 11):3316-26. PubMed ID: 26362908
[TBL] [Abstract][Full Text] [Related]
40. ADC mapping of neurodegeneration in the brainstem and cerebellum of patients with progressive ataxias.
Della Nave R; Foresti S; Tessa C; Moretti M; Ginestroni A; Gavazzi C; Guerrini L; Salvi F; Piacentini S; Mascalchi M
Neuroimage; 2004 Jun; 22(2):698-705. PubMed ID: 15193598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
